A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for ...

A Japanese research team has found a new way to curb cancer cells in the immune system and are now pushing for a clinical ...

More information: Kay Hänggi et al, Interleukin-1α release during necrotic-like cell death generates myeloid-driven ...

Cancer cell death via necroptosis can be accompanied by the release of IL-1a, which can restrict anticancer immunity and ...

Severe infection with Covid-19 has been found to produce a powerful cancer-fighting cell that can shrink tumors.

Researchers discovered that severe COVID infection causes the body to produce a special type of monocyte with anti-cancer ...

The most comprehensive map of the developing human thymus sheds light on how immune responses are built and maintained at ...

A spin-out from the University of Edinburgh in Scotland is already equipped with 15 million pounds ($19 million) in seed ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

The study also showed that the RNA in the COVID-19 virus could incite the production of new immune cells that target and ...

It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...